Cyclerion Therapeutics Inc (CYCN) Live Share Price, Invest From India

Cyclerion Therapeutics Inc Stock Performance

as on May 8, 2026 at 4:10 am IST

Day's Low
Day's High
$3.09
Day's Price Range
$3.19
$3.14
1.59%
Downside
1.59%
Upside
52 Week's Low
52 Week's High
$1.03
52-Week Price Range
$8.48
$3.14
67.31%
Downside
170.06%
Upside

Cyclerion Therapeutics Inc share price movements today

Previous Close: $3.24
Open: $3.19
Volume: 371.4K
Day's Low - High: $3.09 - $3.19
52 Week Low - High: $1.03 - $8.48

Cyclerion Therapeutics Inc Historical Returns

1 Month Return: -6.9 %
3 Month Return: + 194.55 %
1 Year Return: -5.54 %
3 Year Return: -42.74 %
5 Year Return: -94.13 %

Cyclerion Therapeutics Inc Stock Fundamentals & Key Indicators

Check Cyclerion Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$14.0M

EPS (TTM)

-1.2

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-9.6M

Revenue (TTM)

2.1M

Profit Margin

-170.11%

Return On Equity TTM

-39.34%

Cyclerion Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cyclerion Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Cyclerion Therapeutics Inc	BUY	$14.0M	-94.13%	NA	-170.11%
Alnylam Pharmaceuticals Inc	BUY	$40.5B	130.77%	76.32	12.55%
BeiGene, Ltd.	NA	$32.5B	NA	70.89	5.37%
Vertex Pharmaceuticals Inc	BUY	$108.5B	98.9%	25.38	35.51%
Regeneron Pharmaceuticals Inc	BUY	$75.6B	45.15%	17.6	29.65%

Stock Returns calculator for Cyclerion Therapeutics Inc Stock including INR - Dollar returns

The Cyclerion Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Cyclerion Therapeutics Inc investment value today

Current value as on today

₹1,01,830

Returns

₹1,830

(+1.83%)

Returns from Cyclerion Therapeutics Inc Stock

-₹8,455 (-8.45%)

Dollar Impact

₹10,285 (+10.29%)

Analyst Recommendation on Cyclerion Therapeutics Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Cyclerion Therapeutics Inc. Average target price of $8

Cyclerion Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Cyclerion Therapeutics Inc.

What analysts predicted

60.75%UPSIDE

Target Price

Current Price

$3.14

Analyzed by

7 Analysts

Target

$8.00

Cyclerion Therapeutics Inc target price $8, a slight upside of 60.75% compared to current price of $3.14. According to 7 analysts rating.

Indian Investors' Interest in Cyclerion Therapeutics Inc Stock

Search interest for Cyclerion Therapeutics Inc Stock has decreased by -66% in the last 30 days, reflecting a downward trend in search activity.

Time period: April 7, 2026 to May 7, 2026

Change:-66% versus previous 30 day period

Cyclerion Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	-	-	-	0	1	0	0	0	1
Gross Profit	-	-	-	-	0	1	0	0	0	1
Operating Income	-6	-1	-1	-1	-1	0	-1	-1	-1	0
EBITDA	-2	-1	-1	-1	-1	0	-1	-1	0	0
Interest Expense	-	0	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-5	-1	-1	-1	0	0	-1	0	0	0
Income Tax Expense	-16	17	0	-	-	-	-	-	-	-
Net Income	7	-1	-1	-1	0	0	-1	0	0	0
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-372.68%	29.35%	-1764.20%	-348.39%	-111.54%	-77.95%

Cyclerion Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	4	2	3	0	-	2	2
Gross Profit	-2	-1	-1	-90	-54	3	-5	-	2	2
Operating Income	-63	-93	-115	-125	-81	-55	-18	-12	-3	-4
EBITDA	-61	-92	-113	-122	-80	-53	-18	-9	-3	-4
Interest Expense	-	-	-	-	0	0	0	-	-	-
Depreciation	-	1	1	2	2	0	0	-	-	-
Income Before Tax	-63	-93	-115	-123	-77	-51	-18	-12	-3	-3
Income Tax Expense	-	-	1	-2	-5	0	0	8	-	-
Net Income	-63	-93	-115	-123	-77	-51	-44	-5	-3	-3
Net Profit Margin	0.00%	0.00%	0.00%	-2729.27%	-3388.59%	-1555.63%	-14841.08%	0.00%	-152.85%	-170.11%

Cyclerion Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-1	-1	-1	0	0	-1	0	0	0
Operating Cash Flow	-1	-1	-1	-1	0	0	0	0	-1
Investing Cash Flow	-10	-	-	-	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-	1	0	1	0
Change in Cash	-1	-1	-1	-1	0	0	0	1	-1

Cyclerion Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-93	-115	-123	-77	-51	-18	-12	-3	-3
Operating Cash Flow	-81	-97	-102	-72	-36	-40	-21	-4	-3
Investing Cash Flow	-1	-3	-6	0	1	-	10	-	-
Financing Cash Flow	82	100	211	28	30	0	5	-	3
Change in Cash	102	102	102	-44	-4	-40	-5	-4	0

Global Institutional Holdings in Cyclerion Therapeutics Inc

Funds	Holdings
BNP Paribas Arbitrage, SA	0%
UBS Group AG	0%
Siren, L.L.C.	2.67%
Barclays PLC	0%
SBI Securities Co Ltd	0%

See all

Insights on Cyclerion Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 3 months, CYCN stock has moved up by 194.5%
NO EFFECT
Against Peers
In the last 1 year, BeOne Medicines Ltd has given 34.9% return, outperforming this stock by 40.4%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 25.4% return, outperforming this stock by 68.1%

About Cyclerion Therapeutics Inc

Cyclerion Therapeutics, Inc., a biopharmaceutical company, engages in the development of treatments for serious diseases serious diseases with novel sGC stimulators in both the central nervous system (CNS) and the periphery. The company is developing Olinciguat, an orally administered vascular soluble guanylate cyclase (sGC) stimulator, which is in Phase 2 clinical trial to treat cardiovascular diseases; and Praliciguat, a systemic sGC stimulator for the treatment of rare kidney disease. It has a license agreement with Akebia to develop, manufacture, medical affair, and commercializes Praliciguat and other related products. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.

Organisation	Cyclerion Therapeutics Inc
Headquarters	245 First Street, Riverview II, Cambridge, MA, United States, 02142
Industry	Biotechnology
CEO	Dr. Regina M. Graul Ph.D.
E-voting on shares	Click here to vote

Key Management of Cyclerion Therapeutics Inc

Name	Title
Dr. Regina M. Graul Ph.D.	CEO, President & Director
Ms. Rhonda M. Chicko CPA	Chief Financial Officer

FAQs

What is Cyclerion Therapeutics Inc share price today?

Cyclerion Therapeutics Inc share price today is $3.14 as on May 7, 2026 at 10:40 pm IST. Cyclerion Therapeutics Inc share today touched a day high of $3.19 and a low of $3.09.

What is the 52 week high and 52 week low for Cyclerion Therapeutics Inc share?

Cyclerion Therapeutics Inc share touched a 52 week high of $8.48 on April 1, 2026 and a 52 week low of $1.03 on February 9, 2026. Cyclerion Therapeutics Inc stock price today i.e. May 7, 2026 at 10:40 pm IST is trending at $3.14,which is 62.97% down from its 52 week high and 205.86% up from its 52 week low.

What is Cyclerion Therapeutics Inc's market capitalisation today?

Cyclerion Therapeutics Inc market capitalisation is $0.00T as on May 7, 2026 at 10:40 pm IST.

How to invest in Cyclerion Therapeutics Inc Stock (CYCN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Cyclerion Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cyclerion Therapeutics Inc Shares that will get you 0.4777 shares as per Cyclerion Therapeutics Inc share price of $3.14 per share as on May 7, 2026 at 10:40 pm IST.

What is the minimum amount required to buy Cyclerion Therapeutics Inc Stock (CYCN) from India?

Indian investors can start investing in Cyclerion Therapeutics Inc (CYCN) shares with as little as ₹94.24 or $1 (as of May 7, 2026 at 10:40 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹942.40 in Cyclerion Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on May 7, 2026 at 10:40 pm IST). Based on Cyclerion Therapeutics Inc share’s latest price of $3.14 as on May 7, 2026 at 10:40 pm IST, you will get 3.1847 shares of Cyclerion Therapeutics Inc. Learn more about fractional shares .

What are the returns that Cyclerion Therapeutics Inc has given to Indian investors in the last 5 years?

Cyclerion Therapeutics Inc stock has given -94.13% share price returns and 29.81% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?